Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Cannon

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology|February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 StudyR C Becker, J S Hochman, C P Cannon, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Journal of the American College of Cardiology|March 18, 1999
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial InfarctionK A Ault, C P Cannon, J Mitchell, et al.
Journal of the American College of Cardiology|November 25, 2000
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudyD A Morrow, E M Antman, M Tanasijevic, et al.
The American Journal of Cardiology|April 1, 1993
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseC P Cannon, J M Maraganore, J Loscalzo, et al.
American Heart Journal|January 8, 1999
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial InfarctionJ R Kizer, C P Cannon, C H McCabe, et al.
Annals of Human Genetics|October 19, 2006
Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemiaJ Suk Danik, D I Chasman, C P Cannon, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology|February 11, 1999
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 StudyR C Becker, J S Hochman, C P Cannon, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Journal of the American College of Cardiology|March 18, 1999
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial InfarctionK A Ault, C P Cannon, J Mitchell, et al.
Journal of the American College of Cardiology|November 25, 2000
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudyD A Morrow, E M Antman, M Tanasijevic, et al.
The American Journal of Cardiology|April 1, 1993
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseC P Cannon, J M Maraganore, J Loscalzo, et al.
American Heart Journal|January 8, 1999
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial InfarctionJ R Kizer, C P Cannon, C H McCabe, et al.
Annals of Human Genetics|October 19, 2006
Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemiaJ Suk Danik, D I Chasman, C P Cannon, et al.
Pageof 15